Digital stethoscope and ECG for athletes by Croatian Biotech Startup Amicoeur

AMICOEUR™ (Ami - French - friend; Coeur - French - heart) combines ECG and digital stethoscope technology, into a portable device for unprecedented insight into cardiac and pulmonary function. Review rhythms and sounds quickly from the accompanying mobile application for advanced bedside analysis or groundbreaking remote care.

AMICOEUR™ amplifies body sounds 50X and transmits it’s audio and ECG data to a smart device via Bluetooth. In a mobile app user can open and playback sounds and visualise phonocardiograms (PCG) for better analysis. App enables you to save relevant audio recordings and ECG waveforms, annotate notes on them and safely share them or live stream for a quick second-opinion. It enables data collection for multiple patients, creating their medical files, and entering patient’s personal and family anamnesis for a complete insight, easier diagnosis and continuous monitoring. Device is made of a material that is dust-proof, sweat-proof and impact-resistant while shaped in size to fit practically in the palm of your hand.

The sports medicine market is estimated to grow at $ 12 billion before 2025, with a growing trend of telemedicine services and devices that, instead of treatment, focus on regular and independent prevention and review. Amicoeur™ is focusing on 3.5b $ virtual healthcare market with specific goal of helping professional athletes and sport teams in prevention of sudden cardiac death, defined as the most prevalent cause of death among athletes.

Amicoeur should hit the market by Q1 2022 stated company leadership.

Company: Amicoeur
Street: J.J. Strossmayera
31000 Osijek, Croatia, EU
Amicoeur PR Contact

Digital stethoscope and ECG for cardiac function analysis and diagnosis for professional athletes by Croatian biotech startup Amicoeur.

This release was published on openPR.